ArticleScientific reports2025
Impact of epstein-barr virus reactivation on cytokine levels in pregnant women with malaria in the west region of cameroon.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diagnostic value of combined flow cytometry-based detection of peripheral blood lymphocyte subsets and cytokines for pediatric infectious mononucleosis.Frontiers in pediatrics · 2026Article
- Epstein-Barr virus reactivation triggers selective IL-6/IL-10 axis inflammation and CD3Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
We have previously reported that pregnant women with EBV reactivation are more prone to severe malaria than those with latent EBV. This suggests that lytic reactivation of EBV is strongly associated with malaria severity and could be investigated as a risk factor for severe malaria during pregnancy. To understand the association between EBV reactivation and malaria severity, we investigated the levels of IL-6, IFN-γ, TNF-α, IL-10, and TGF-β in pregnant women with malaria and reactivated EBV vs. latent EBV. A total of 220 pregnant women were recruited from three hospitals in the West region of Cameroon. Malaria was diagnosed by microscopy and Nested PCR, while EBV reactivation was assessed by detecting EBV nuclear antigen IgG, viral capsid antigen IgM, and early antigen IgG using ELISA. Cytokine levels were measured by ELISA, and data were analyzed using GraphPad Prism version 9.0. Women with reactivated EBV and severe malaria showed significantly lower IL-6 levels compared to those with latent EBV and severe malaria (29.86 pg/ml vs. 55.83 pg/ml, p = 0.02). Interestingly, TGF-β levels were significantly elevated in women with reactivated EBV and severe malaria than those with latent EBV and severe malaria (17.6 pg/ml vs. 6.1 pg/ml, p = 0.01). A strong negative correlation was observed between IL-10 levels and parasitemia in women with reactivated EBV and severe malaria (r=-0.9762, p = 0.0004). Our data revealed that lytic EBV reactivation may impair the inflammatory response by down-regulating the IL-6 level and elevating the TGF-β level, contributing to a loss of control of the parasitemia and potentially exacerbating malaria. This study provides further insight into the immunological interaction between EBV and P. falciparum and could contribute to improving malaria therapies in EBV-infected malaria patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.